夏宁邵 (NingShao Xia)
生命科学学院
ResearcherID:G-4647-2010
2023年当选中国工程院院士。 入选中国医学科学院学部委员、国家杰出青年科学基金、教育部“长江学者奖励计划”特岗学者、国家特支计划科技创新领军人才、全国先进工作者、全国杰出专业技术人才、国家百千万人才工程。以第一完成人获国家技术发明二等奖、国家科技进步二等奖、全国创新争先奖、中国专利金奖、福建省科技重大贡献奖、厦门市科技重大贡献奖、求是杰出科技成就集体奖、转化医学杰出贡献奖。
已发表成果:
WOK 论文 557 篇;中文核心 176 篇;其它论文 55 篇;专利发明 57 个;
Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids
A novel point-of-care test of respiratory syncytial viral RNA based on cellulose-based purification and convective PCR
Early diagnosis and population prevention of coronavirus disease 2019
Molecular characterization of an uncommon multigene Reassortant G1P[4] rotavirus identified in China
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China
A plasma separator with a multifunctional deformable chamber equipped with a porous membrane for point-of-care diagnostics
Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages
Expression Level of Small Envelope Protein in Addition to Sequence Divergence inside Its Major Hydrophilic Region Contributes to More Efficient Surface Antigen Secretion by Hepatitis B Virus Subgenotype D2 than Subgenotype A2
Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks
Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans
Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
DLL4 restores damaged liver by enhancing hBMSC differentiation into cholangiocytes
Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial
Structure guided maturation of a novel humanized anti-HBV antibody and its preclinical development
Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent
Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions
Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
An immunoassay cassette with a handheld reader for HIV urine testing in point-of-care diagnostics
Rapid Neutralization Testing System for Zika Virus Based on an Enzyme-Linked Immunospot Assay
Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade
EGFR-targeted CAR-T cells are potent and specific in suppressing triple-negative breast cancer both in vitro and in vivo
High-Efficiency Plasma Separator Based on Immunocapture and Filtration
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women
Recent Progress on the Versatility of Virus-Like Particles
Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16
A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in mice
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
Animal models for emerging coronavirus: progress and new insights
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells
Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens
Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods
Sex Differences in the Incidence and Clearance of Anogenital Human Papillomavirus Infection in Liuzhou, China: An Observational Cohort Study
Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation
Room-temperature-storable PCR mixes for SARS-CoV-2 detection
Free convective PCR: From principle study to commercial applications-A critical review
Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
Nucleic Acid Testing for Coronavirus Disease 2019: Demand, Research Progression, and Perspective
COVID-19: Progress in diagnostics, therapy and vaccination
大肠杆菌表达系统在基因工程疫苗研发中的应用与策略优化
中国新药杂志,1003-3734,2020-11-15.双价人乳头瘤病毒疫苗(大肠杆菌)的有效性研究:一项随机对照临床试验的中期分析
中国妇产科临床杂志,1672-1861,2020-11-15.疫苗免疫原的研究进展和趋势
中国科学基金,1000-8217,2020-10-25.寨卡病毒衣壳蛋白单克隆抗体的制备及性能评价
中国病原生物学杂志,1673-5234,2020-08-30.细菌糖基化基本元件及其应用研究进展
微生物学报,0001-6209,2020-08-07.质粒转染比例对人乳头瘤病毒16/18型假病毒制备的影响
病毒学报,1000-8721,2020-06-08.抗原检测在戊型肝炎临床诊断中的应用
病毒学报,1000-8721,2020-06-05.新型冠状病毒抗体检测试剂的临床性能评估方案
病毒学报,1000-8721,2020-04-24.人乳头瘤病毒治疗性疫苗的研究进展
病毒学报,1000-8721,2020-02-13.